<?xml version="1.0" encoding="UTF-8" standalone="no"?><information><Cell><NavigationPath><Head00>Variable</Head00><Stub><StubValue>Primary site</StubValue></Stub><HeaderValue>Response (%) Response rate</HeaderValue></NavigationPath><value>33/35 (94.3)</value><CellType>Partially Numeric</CellType></Cell><Table><TableType>Matrix</TableType><tableName>Tumour response (intent-to-treat analysis, N=37)</tableName><tableOrder>Table 2</tableOrder><tableFooter>CR=complete response; PR=partial response; SD=stable disease; PD=progressive disease.</tableFooter></Table><Document><DocumentTitle>Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck</DocumentTitle><PMC>2361495</PMC></Document></information>